ONCSM Stock Overview
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi provides consumables, medical devices, diagnostic products, and protective equipment.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺179.50 |
| 52 Week High | ₺288.80 |
| 52 Week Low | ₺52.95 |
| Beta | 0 |
| 1 Month Change | -4.52% |
| 3 Month Change | 1.13% |
| 1 Year Change | 131.61% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 832.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| ONCSM | TR Medical Equipment | TR Market | |
|---|---|---|---|
| 7D | 7.8% | 3.9% | 3.2% |
| 1Y | 131.6% | -7.8% | 131.1% |
Return vs Industry: ONCSM exceeded the TR Medical Equipment industry which returned -9% over the past year.
Return vs Market: ONCSM exceeded the TR Market which returned 122.6% over the past year.
Price Volatility
| ONCSM volatility | |
|---|---|
| ONCSM Average Weekly Movement | 7.3% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 7.8% |
| 10% most volatile stocks in TR Market | 11.9% |
| 10% least volatile stocks in TR Market | 5.6% |
Stable Share Price: ONCSM's share price has been volatile over the past 3 months.
Volatility Over Time: ONCSM's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 324 | Erol Celik | www.oncosem.com |
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi provides consumables, medical devices, diagnostic products, and protective equipment. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It also provides Oncosem components, such as pinch clamps, roller clamps, 3/4 way connectors, vial adapters, drip chambers, hydrophobic caps, male and rotating luer locks, spikes, taxol filters, check valves, and covers.
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi Fundamentals Summary
| ONCSM fundamental statistics | |
|---|---|
| Market cap | ₺4.28b |
| Earnings (TTM) | -₺79.81m |
| Revenue (TTM) | ₺240.51m |
17.8x
P/S Ratio-53.6x
P/E RatioIs ONCSM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ONCSM income statement (TTM) | |
|---|---|
| Revenue | ₺240.51m |
| Cost of Revenue | ₺204.72m |
| Gross Profit | ₺35.79m |
| Other Expenses | ₺115.60m |
| Earnings | -₺79.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.35 |
| Gross Margin | 14.88% |
| Net Profit Margin | -33.18% |
| Debt/Equity Ratio | 26.2% |
How did ONCSM perform over the long term?
See historical performance and comparison